Skip to content
Back to Investors
IP Group

IP Group

Venture Capital

IP Group is an investor focused on turning companies with outstanding innovations into successful businesses.


Recent investments

Series B
£35.0M

HydrogenOne Capital Growth led the Series B round with support from IP Group, Parkwalk Advisors, BGF, and the UCL Technology Fund.

"Hydrogen, through its green production from electrolysis or its use in fuel cells to provide clean power, is critical for the transition to net zero. Bramble Energy brings a fundamentally different approach to these technologies, unlocking the deployment of hydrogen faster, more flexibly and at scale. We are delighted to contribute substantially to this significant funding round which will take Bramble to the next stage."
— Jamie Vollbracht, Partner, Cleantech
Series A
£9.5M

The Oxford Science Enterprises-led round will support US expansion and continued domestic growth in healthcare.

"I’m delighted our investors have again demonstrated their belief in the vast potential that Navenio can bring by ensuring ‘right person, right place, right time’. Artificial intelligence is one of many technologies making a real-world impact in the health sector, and this investment enables the company to rapidly spearhead international digital transformation."
— Niki Trigoni, Founder and CTO
Series B
£39.0M

Morningside led the Series B financing to support regulatory approvals and market entry for clinical software treatments.

"At ieso, we’re looking to transform global mental health by unlocking the power of clinical data to develop AI-enabled digital therapeutics. Our experience delivering outstanding mental health care within the NHS ideally places us for starting to tackle this challenge. A new generation of clinically-validated digital mental health care products could ultimately improve millions of lives. But we cannot do this alone, and look forward to working with our patients, clinicians, investors, as well as existing and future partners, to better serve those who require mental health support."
— Nigel Pitchford, CEO
Series D+
£60.0M

The financing round was backed by Tencent, British Patient Capital, CMB International, Mayfair Equity Partners, and IP Group.

"The metaverse concept is not new to Ultraleap. It has always been our mission to remove boundaries between physical and digital worlds. The pandemic has accelerated the rise of the term as more people now understand the power of enhancing the physical world with digital elements."
— Tom Carter, CEO